Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines

CANNANNEW REPORT

– Vaccine Candidate Well Tolerated and Effective in Cohort – – Strong Neutralizing Antibody Titer Elicited Across Cohort – STONY… Read More…..

Excerpt only …
READ MORE BELOW
Source : Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.